Triclofos Sodium for Pediatric Sedation in Non-Painful Neurodiagnostic Studies
Triclofos sodium (TFS) has been used for many years in children as a sedative for painless medical procedures. It is physiologically and pharmacologically similar to chloral hydrate, which has been censured for use in children with neurocognitive disorders. The aim of this study was to investigate the safety and efficacy of TFS sedation in a pediatric population with a high rate of neurocognitive disability.
The database of the neurodiagnostic institute of a tertiary academic pediatric medical center was retrospectively reviewed for all children who underwent sedation with TFS in 2014. Data were collected on demographics, comorbidities, neurologic symptoms, sedation-related variables, and outcome.
The study population consisted of 869 children (58.2% male) of median age 25 months (range 5–200 months); 364 (41.2%) had neurocognitive diagnoses, mainly seizures/epilepsy, hypotonia, or developmental delay. TFS was used for routine electroencephalography in 486 (53.8%) patients and audiometry in 401 (46.2%). Mean (± SD) dose of TFS was 50.2 ± 4.9 mg/kg. Median time to sedation was 45 min (range 5–245), and median duration of sedation was 35 min (range 5–190). Adequate sedation depth was achieved in 769 cases (88.5%). Rates of sedation-related adverse events were low: apnea, 0; desaturation ≤ 90%, 0.2% (two patients); and emesis, 0.35% (three patients). None of the children had hemodynamic instability or signs of poor perfusion. There was no association between desaturations and the presence of hypotonia or developmental delay.
TFS, when administered in a controlled and monitored environment, may be safe for use in children, including those with underlying neurocognitive disorders.
We thank Mrs Pnina Lilos for her insights regarding the study design and assistance in the data analysis and interpretation.
Compliance with Ethical Standards
Conflict of interest
All authors including EK, AD, AW, DK, GK, RM, and EN have no conflicts of interest to disclose.
No funding was secured for this study.
Ethical approval and informed consent
The study was approved by the Institutional Review Board of Schneider Children’s Medical Center of Israel with a waiver of parental consent owing to the retrospective study design (RMC-0010-15).
- 4.Chloral hydrate. Drug facts and comparisons. Efacts. Philadelphia: Wolters Kluwer Health, Inc; 2006.Google Scholar
- 7.Buck ML. Chloral hydrate use during infancy. Neonatal Pharmacol Quart. 1992;1:31–7.Google Scholar
- 8.Twite MD, Rashid A, Zuk J, Friesen RH. Sedation, analgesia, and neuromuscular blockade in the pediatric intensive care unit: survey of fellowship training program. Pediatr Crit Care Med. 2004;5(6):521–32. https://doi.org/10.1097/01.PCC.0000144710.13710.2E.CrossRefGoogle Scholar
- 17.Coté CJ, Wilson S. Guidelines for monitoring and management of pediatric patients before, during, and after sedation for diagnostic and therapeutic procedures: update 2016. Pediatr Dent. 2016;38(4):13–39.Google Scholar
- 21.Millichap JG. Electroencephalographic evaluation of triclofos sodium sedation in children. Am J Dis Child. 1972;124(4):526–7.Google Scholar
- 23.Sammons H, Choonara I, Alotaibi B. Safety and clinical effectiveness of triclofos for procedural sedation in children: a systemic review. Arch Dis Child. 2015;100(6):e1.Google Scholar
- 25.ASA Physical Status classification system (ASA PS): American Society of Anesthesiologists: October 15, 2014. https://www.asahq.org/resources/clinical-information/asa-physical-status-classification-system. Accessed 9 July 2019.
- 28.Kliegman RM, Stanton B, St Geme J, Schor NF, Behrman RE. Nelson textbook of pediatrics. 20th ed. New York: Elsevier; 2016.Google Scholar
- 29.Ralston M. Pediatric advanced life support provider manual. Dallas: American Heart Association; 2006.Google Scholar
- 30.Cravero JP, Beach ML, Blike GT, Gallagher SM, Hertzog JH, Pediatric Sedation Research Consortium. The incidence and nature of adverse events during pediatric sedation/anesthesia with propofol for procedures outside the operating room: a report from the Pediatric Sedation Research Consortium. Anesth Analg. 2009;108(3):795–804. https://doi.org/10.1213/ane.0b013e31818fc334.CrossRefGoogle Scholar
- 37.Gumus H, Bayram AK, Poyrazoglu HG, Canpolat DG, Per H, Canpolat M, Yildiz K, Kumandas S. Comparison of effects of different dexmedetomidine and chloral hydrate doses used in sedation on electroencephalography in pediatric patients. J Child Neurol. 2015;30(8):983–8. https://doi.org/10.1177/0883073814549582.CrossRefGoogle Scholar